8:00 AM
Welcome and Overview
Carolyn R. (“Bo”) Aldigé, Prevent Cancer Foundation
James L. Mulshine, MD, Rush University Medical Center
View slideshow (PDF)
8:30 AM
Keynote: Strategies for Accelerating Quantitative Imaging Regulatory Approval at the FDA
Kyle Myers, PhD, US Food and Drug Administration
9:30 AM
2017 James L. Mulshine, MD National Leadership Award
John W. Walsh, Founder, COPD Foundation
Posthumous award to be accepted by Sue Walsh Ferro
10:00 AM
Progress Towards an International Image Quality Monitoring Framework for Quantitative Imaging
Ricardo Avila, MS, Accumetra, LLC — View slideshow (PDF)
10:30 AM
Emerging Issues with Quantitative Imaging
David Gierada, MD, Washington University School of Medicine
View slideshow (PDF)
11:00 AM
Performance and Characterization of Quantitative Imaging Solutions for Lung Nodules and Lesions
Nick Petrick, PhD, US Food and Drug Administration
11:30 AM
Cost Implications of CT Imaging in Lung Cancer Screening
Bruce Pyenson, FSA, MAAA, Milliman, Inc.
View slideshow (PDF)
1:00 – 3:30 PM
COPD Session
Chair: Raúl San José Estépar, PhD, Brigham and Women’s Hospital, Harvard Medical School
1:00 PM
Harmonization of CT for Densitometry Analysis
Raúl San José Estépar, PhD, Brigham and Women’s Hospital, Harvard Medical School
View slideshow (PDF)
1:30 PM
Application of Quantitative CT in the Management of COPD
David Lynch, MD, National Jewish Health
View slideshow (PDF)
2:00-3:00 PM
COPD Panel Session: What Are the Next Steps to Integrate COPD
Chair: Raúl San José Estépar, PhD, Brigham and Women’s Hospital, Harvard Medical School
David Lynch, MD, National Jewish Health
Russell Bowler, MD, PhD, National Jewish Health
Anthony Reeves, PhD, Cornell University
3:00 PM
Screening Implementation: Current Practices and Continued Implementation Challenges
Amy Copeland, MPH, Lung Cancer Alliance
View slideshow (PDF)
3:45-4:45 PM
Stakeholder Panel on Quality
Chair: Anthony Reeves, PhD, Cornell University
Ricardo Avila, MS, Accumetra, LLC
Richard Frank, MD, PhD, Siemens Healthineers — View slideshow (PDF)
Annette Schmid, PhD, Takeda — View slideshow (PDF)
Laurie Fenton Ambrose, Lung Cancer Alliance
4:45-6 PM
Breakout Sessions
Topic A – Policy Proposal: Reframing Precision Imaging as a Public Health Tool to Reduce Tobacco-related Deaths
Topic B –Technical Proposal: Innovative Quality Processes for Population-health Based Management of Presymptomatic Tobacco-related Disease
8:00 – 9:00 AM
Issues with Cardiac & Radiomics Imaging With Lung Cancer Screening
Chair: David Yankelevitz, MD, PhD, Icahn School of Medicine at Mount Sinai Hospital
8:00 AM
Update on Addressing the Cardiac Health Potential with Lung Cancer Screening
Harvey Hecht, MD, Icahn School of Medicine at Mount Sinai Hospital
View slideshow (PDF)
8:30 AM
Opportunities with Radiomics in Lung Cancer Screening
Anthony Reeves, PhD, Cornell University
9:00 – 10:00 AM
Breakout sessions
Topic A – Policy Proposal: Reframing Precision Imaging as a Public Health Tool to Reduce Tobacco-related Deaths
Topic B – Technical Proposal: Innovative Quality Processes for Population-health Based Management of Presymptomatic Tobacco- related Disease
10:15 AM – 12:00 PM
Lung Cancer Screening Adoption in the US and the World
Chairs: Claudia Henschke, MD, PhD, Icahn School of Medicine at Mount Sinai Hospital and Richard Frank, MD, PhD, Siemens Healthineers
10:15 AM
Panel Discussion: Precision Imaging and Value-based Reimbursement – Can We Sustain Innovation?
Chair: Richard Frank, MD, PhD, Siemens Healthineers
Bruce Pyenson, FSA, MAAA, Milliman, Inc.
Laurie Fenton Ambrose, Lung Cancer Alliance
David Yankelevitz, MD, PhD, Icahn School of Medicine at Mount Sinai Hospital
Annette Schmid, PhD, Takeda
11:15 AM
Bold Plans To Overcome Health Disparities: Using Imaging, Prevention and Big Data with Tobacco-related Diseases
Tochukwu M. Okwuosa, DO, Rush University Medical Center
View slideshow (PDF)
11:45 AM – 12:45 PM
Breakout Group Presentations and Discussion
Topic A – Policy Proposal: Reframing Precision Imaging as a Public Health Tool to Reduce Tobacco-related Deaths
Topic B – Innovative Quality Processes for Population-health Based Management of Presymptomatic Tobacco-related Disease
12:45 – 1:00 PM
Summary and Action Plans
1:00 PM
Workshop Adjourns
